Danaher Corporation (LON:0R2B)

Market Cap	112.79B -19.7%
Revenue (ttm)	18.25B +2.9%
Net Income	2.69B -7.3%
EPS	3.75 -4.5%
Shares Out	n/a
PE Ratio	42.00
Forward PE	25.70
Dividend	0.95 (0.43%)
Ex-Dividend Date	Dec 26, 2025

Volume	483
Average Volume	2,090
Open	217.19
Previous Close	219.30
Day's Range	215.00 - 220.93
52-Week Range	171.02 - 244.50
Beta	0.93
RSI	33.90
Earnings Date	Jan 28, 2026

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1969
• Employees: 63,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R2B

Financial Performance

In 2025, Danaher's revenue was $24.57 billion, an increase of 2.90% compared to the previous year's $23.88 billion. Earnings were $3.61 billion, a decrease of -7.31%.

Financial numbers in USD